Literature DB >> 22212350

Peripheral painful traumatic trigeminal neuropathies.

R Benoliel1, J Kahn, E Eliav.   

Abstract

The aim of this article is to review the clinical, pathophysiological, and therapeutic aspects of traumatically induced trigeminal nerve pain. We introduce a new and, in our view, more accurate terminology: peripheral painful traumatic trigeminal neuropathy (PPTTN) to define this patient group. The proposed pathophysiology of PPTTN is largely based on studies in spinal nerve injury models. However, trigeminal nerve injury studies have shown some subtle differences in response to physical and inflammatory insults, and these are discussed. The treatment of painful neuropathies is difficult and carries a poor prognosis. Based on the available literature on efficacy and side effects, we propose a treatment algorithm for traumatic trigeminal neuropathies.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22212350     DOI: 10.1111/j.1601-0825.2011.01883.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  10 in total

1.  Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABAA receptors.

Authors:  Dina Vasović; Branka Divović; Marco Treven; Daniel E Knutson; Friederike Steudle; Petra Scholze; Aleksandar Obradović; Jure Fabjan; Božidar Brković; Werner Sieghart; Margot Ernst; James M Cook; Miroslav M Savić
Journal:  Eur J Pain       Date:  2019-02-04       Impact factor: 3.931

2.  Persistent, neuropathic-like trigeminal pain after dental implant loading.

Authors:  Ndiaye Amadou-Diaw; Adeline Braud; Yves Boucher
Journal:  J Clin Exp Dent       Date:  2022-02-01

3.  Factors associated with current and severe pain among people living with HIV: results from a statewide sample.

Authors:  Verlin Joseph; Abenaa Jones; Shantrel Canidate; Zachary Mannes; Huiyin Lu; Nichole Ennis; Gladys Ibanez; Charurut Somboonwit; Robert Cook
Journal:  BMC Public Health       Date:  2020-09-18       Impact factor: 3.295

4.  Role of voltage-gated sodium channels in axonal signal propagation of trigeminal ganglion neurons after infraorbital nerve entrapment.

Authors:  Yatendra Mulpuri; Toru Yamamoto; Ichiro Nishimura; Igor Spigelman
Journal:  Neurobiol Pain       Date:  2022-01-21

5.  Atypical odontalgia and trigeminal neuralgia: psychological, behavioral and psychopharmacological approach in a dental clinic - an overview of pathologies related to the challenging differential diagnosis in orofacial pain.

Authors:  Riccardo Tizzoni; Marta Tizzoni; Carlo Alfredo Clerici
Journal:  F1000Res       Date:  2021-04-23

6.  Botulinum toxin A for management of refractory concurrent buccal and inferior alveolar nerve post-traumatic neuropathies: a case report.

Authors:  Chloé Capon; Aurélien Crevant; Armelle Pointin; Arek Sulukdjian; Nathan Moreau
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

Review 7.  Perspectives on next steps in classification of oro-facial pain - part 1: role of ontology.

Authors:  W Ceusters; A Michelotti; K G Raphael; J Durham; R Ohrbach
Journal:  J Oral Rehabil       Date:  2015-07-25       Impact factor: 3.837

8.  KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.

Authors:  Alaa A Abd-Elsayed; Ryo Ikeda; Zhanfeng Jia; Jennifer Ling; Xiaozhuo Zuo; Min Li; Jianguo G Gu
Journal:  Mol Pain       Date:  2015-07-31       Impact factor: 3.395

9.  Altered pain modulation in patients with persistent postendodontic pain.

Authors:  Cibele Nasri-Heir; Junad Khan; Rafael Benoliel; Changyong Feng; David Yarnitsky; Fengshen Kuo; Craig Hirschberg; Gary Hartwell; Ching-Yu Huang; Gary Heir; Olga Korczeniewska; Scott R Diehl; Eli Eliav
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

10.  A Case of Post-traumatic Persistent Nasal Pain.

Authors:  Marta Puma; Barbara Petolicchio; Alessandro Viganò; Ilaria Maestrini; Vittorio Di Piero
Journal:  Front Neurol       Date:  2020-02-03       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.